Aaron Hupman, MD
General Practice · Lilburn, GANPI 1184764128
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,000 of the $11,216 with a category attached, or 89.2%. AbbVie accounts for 92.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $10,107 and has fallen 98.8% since, to $119 in 2025. Among general practice clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $169.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- AstraZeneca$266
- Amgen$156
- Boehringer Ingelheim$101
- Novo Nordisk$87
- Amarin Pharma, Inc.$85
- plus $158 from 6 others
What the payments were for
- Speaking & faculty fees$10,00089%
- Food & beverage$1,17010%
- Education$460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $10,363 |
| AstraZeneca | 11 | $266 |
| Amgen | 8 | $156 |
| Boehringer Ingelheim | 5 | $101 |
| Novo Nordisk | 5 | $87 |
| Amarin Pharma, Inc. | 5 | $85 |
| Merck | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Johnson & Johnson | 2 | $33 |
| Intuitive Surgical | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$11,216 in reported general payments places this provider in the 95th percentile of 2,542 general practice providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $62,482 |
| FarxigaDapagliflozin Propanediol | 23 | $24,824 |
| MyrbetriqMirabegron | 34 | $21,845 |
| GlyxambiEmpagliflozin/Linagliptin | 14 | $17,949 |
| SynthroidLevothyroxine Sodium | 31 | $4,101 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $3,889 |
| Lisdexamfetamine Dimesylate | 13 | $3,074 |
| Rosuvastatin Calcium | 147 | $2,011 |
| Levothyroxine Sodium | 114 | $1,435 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 11 | $1,346 |
| Adacel TdapDiph,pertuss(Acell),tet Vac/Pf | 19 | $1,324 |
| Atorvastatin Calcium | 116 | $1,086 |
| Temazepam | 12 | $1,072 |
| Azelastine Hcl | 28 | $942 |
| Gabapentin | 42 | $926 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $87 | $62,48245 claims |
| AstraZenecaFarxiga | $266 | $24,82423 claims |
| Boehringer IngelheimGlyxambi | $101 | $17,94914 claims |
| AbbVieSynthroid | $10,363 | $4,10131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,542 general practice providers in Georgia.
Other general practice in Lilburn
- Edward SchlisselMarietta$665K
- Peter VanstromTucker$424K
- Robert PauleyUnion City$155K
- Stanton McKennaAtlanta$75K
- Carlos TanGainesville$75K
- Michael BoydAugusta$67K
- Harris SiegelAtlanta$54K
- John ComisiAugusta$50K
- Jeffery BradleyLithia Springs$45K
- Ushma PatelSuwanee$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.